SS-31 improved endurance without changing cardiolipin: how is that possible?
Does a peptide binding to cardiolipin on the mitochondrial membrane necessarily have to increase the amount of cardiolipin in order to work?…
Read source review →Continue from catalog navigation into editorial analysis, evidence records and quality-documentation guidance.
Showing 7–12 of 25 reviewed articles · Page 2 of 5
Does a peptide binding to cardiolipin on the mitochondrial membrane necessarily have to increase the amount of cardiolipin in order to work?…
Read source review →Seeing the words “cancer research” makes it easy to think of directly killing tumors. This scoping review of thymosin alpha-1 mainly focuses…
Read source review →A K562 cell experiment reported extensive cell killing. Learn what the measurements show and why they do not establish a cancer treatment.
Read source review →A 2026 cell study found fewer senescence-marker-positive cells with SS-31. Understand the 67% versus 38% result and why it does not mean…
Read source review →Separate the amount of cellular machinery from how well it works.
Read source review →SS-31 is studied for its interaction with a lipid called cardiolipin in the inner mitochondrial membrane. This guide explains that relationship in…
Read source review →If a target is not listed, submit the sequence, scale and specification for a custom-project feasibility review.
Tell us what you need. Your enquiry will be routed to the appropriate contact for catalog numbers, availability and quotation details.